180 related articles for article (PubMed ID: 27482546)
1. Myristoylated p110α Causes Embryonic Death Due to Developmental and Vascular Defects.
Sheen MR; Warner SL; Fields JL; Conejo-Garcia JR; Fiering S
Open Life Sci; 2015 Oct; 10(1):461-478. PubMed ID: 27482546
[TBL] [Abstract][Full Text] [Related]
2. Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer.
Sheen MR; Marotti JD; Allegrezza MJ; Rutkowski M; Conejo-Garcia JR; Fiering S
Oncogenesis; 2016 Oct; 5(10):e267. PubMed ID: 27797363
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defects.
Hare LM; Schwarz Q; Wiszniak S; Gurung R; Montgomery KG; Mitchell CA; Phillips WA
Dev Biol; 2015 Aug; 404(1):14-26. PubMed ID: 25958091
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin.
Zhang T; Yao Y; Wang J; Li Y; He P; Pasupuleti V; Hu Z; Jia X; Song Q; Tian XL; Hu C; Chen Q; Wang QK
Hum Mol Genet; 2016 Dec; 25(23):5094-5110. PubMed ID: 27522498
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in the p110alpha subunit of PI3K results in diminished Tie2 expression and Tie2(-/-)-like vascular defects in mice.
Lelievre E; Bourbon PM; Duan LJ; Nussbaum RL; Fong GH
Blood; 2005 May; 105(10):3935-8. PubMed ID: 15687236
[TBL] [Abstract][Full Text] [Related]
6. Involvement of phosphoinositide 3-kinase class IA (PI3K 110α) and NADPH oxidase 1 (NOX1) in regulation of vascular differentiation induced by vascular endothelial growth factor (VEGF) in mouse embryonic stem cells.
Bekhite MM; Müller V; Tröger SH; Müller JP; Figulla HR; Sauer H; Wartenberg M
Cell Tissue Res; 2016 Apr; 364(1):159-74. PubMed ID: 26553657
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Phosphatidylinositol 3-Kinase p110α and Gene Amplification of PIK3CA in Nasopharyngeal Carcinoma.
Yip WK; He PY; Abdullah MA; Yusoff S; Seow HF
Pathol Oncol Res; 2016 Apr; 22(2):413-9. PubMed ID: 26581613
[TBL] [Abstract][Full Text] [Related]
8. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
Wu CY; Carpenter ES; Takeuchi KK; Halbrook CJ; Peverley LV; Bien H; Hall JC; DelGiorno KE; Pal D; Song Y; Shi C; Lin RZ; Crawford HC
Gastroenterology; 2014 Dec; 147(6):1405-16.e7. PubMed ID: 25311989
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.
Graupera M; Guillermet-Guibert J; Foukas LC; Phng LK; Cain RJ; Salpekar A; Pearce W; Meek S; Millan J; Cutillas PR; Smith AJ; Ridley AJ; Ruhrberg C; Gerhardt H; Vanhaesebroeck B
Nature; 2008 May; 453(7195):662-6. PubMed ID: 18449193
[TBL] [Abstract][Full Text] [Related]
10. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
[TBL] [Abstract][Full Text] [Related]
11. Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.
Young CD; Pfefferle AD; Owens P; Kuba MG; Rexer BN; Balko JM; Sánchez V; Cheng H; Perou CM; Zhao JJ; Cook RS; Arteaga CL
Cancer Res; 2013 Jul; 73(13):4075-85. PubMed ID: 23633485
[TBL] [Abstract][Full Text] [Related]
12. Keratin 5-Cre-driven excision of nonmuscle myosin IIA in early embryo trophectoderm leads to placenta defects and embryonic lethality.
Crish J; Conti MA; Sakai T; Adelstein RS; Egelhoff TT
Dev Biol; 2013 Oct; 382(1):136-48. PubMed ID: 23911870
[TBL] [Abstract][Full Text] [Related]
13. Activation of PI3K/p110α in the Lung Mesenchyme Affects Branching Morphogenesis and Club Cell Differentiation.
Dai H; Zhu M; Li W; Si G; Xing Y
Front Cell Dev Biol; 2022; 10():880206. PubMed ID: 35676931
[TBL] [Abstract][Full Text] [Related]
14. Multiple congenital malformations arise from somatic mosaicism for constitutively active Pik3ca signaling.
Marechal E; Poliard A; Henry K; Moreno M; Legrix M; Macagno N; Mondielli G; Fauquier T; Barlier A; Etchevers HC
Front Cell Dev Biol; 2022; 10():1013001. PubMed ID: 36353506
[TBL] [Abstract][Full Text] [Related]
15. Hot-spot mutations in p110alpha of phosphatidylinositol 3-kinase (pI3K): differential interactions with the regulatory subunit p85 and with RAS.
Zhao L; Vogt PK
Cell Cycle; 2010 Feb; 9(3):596-600. PubMed ID: 20009532
[TBL] [Abstract][Full Text] [Related]
16. In-silico prediction of potential inhibitors against phosphatidylinositol 3-kinase catalytic subunit alpha involved in head and neck squamous cell carcinomas.
Madhukar G; Subbarao N
J Biomol Struct Dyn; 2022 Jul; 40(10):4697-4712. PubMed ID: 33356909
[TBL] [Abstract][Full Text] [Related]
17. Human tumor mutants in the p110alpha subunit of PI3K.
Liu Z; Roberts TM
Cell Cycle; 2006 Apr; 5(7):675-7. PubMed ID: 16627990
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation at tyrosine 317 and 508 are crucial for PIK3CA/p110α to promote CRC tumorigenesis.
Wang T; Sun L; Chen C; Zhang Y; He B; Zhang Y; Wang Z; Xue H; Hao Y
Cell Biosci; 2023 Sep; 13(1):164. PubMed ID: 37689735
[TBL] [Abstract][Full Text] [Related]
19. The role of the PIK3CA gene in the development and aging of the brain.
Xie S; Ni J; Guo H; Luu V; Wang Y; Zhao JJ; Roberts TM
Sci Rep; 2021 Jan; 11(1):291. PubMed ID: 33431926
[TBL] [Abstract][Full Text] [Related]
20. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
